TANDEM DIABETES CARE INC - 8-K Filing
Tandem Diabetes Care reports Q3 2026 worldwide sales of $283.7 million, up 14% YoY, and narrows operating loss to $2.4 million. (Items: 2.02 Results of Operations and Financial Condition, 9.01 Financial Statements and Exhibits)
Tickers: $TNDM
Read the full article at SEC EDGAR
Part of the story Crescent Capital BDC Reports Q3 2026 Earnings with Increased Net Investment Income (48 articles)